Pfizer, Moderna Eye Windfall Profits as COVID Booster Rollout Begins
One analyst predicted COVID boosters alone will bring in about $26 billion in global sales next year for Pfizer — who splits profits with BioNTech — and around $14 billion for Moderna if the shots are endorsed for nearly all Americans.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
